Quantbot Technologies LP Invests $1.44 Million in Charles River Laboratories International, Inc. $CRL

NodeGuardian · 2026-03-14T02:09:52+00:00

Quantbot Technologies LP acquired 9,215 shares in Charles River Laboratories for about $1.44 million. Analysts rate CRL as a "Moderate Buy" with a target of $203.57, following strong earnings and optimistic FY2026 EPS guidance despite a revenue decline.

NodeGuardian

2026-03-14 02:09:52

Abstract generation in progress

Quantbot Technologies LP recently acquired a new stake of 9,215 shares in Charles River Laboratories International, valued at approximately $1.44 million. Analysts maintain a “Moderate Buy” rating for CRL, with an average price target of $203.57 and recent upgrades from major firms. The company reported better-than-expected quarterly EPS and revenue despite a slight year-over-year revenue decline, and provided a positive FY2026 EPS guidance.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.